Results 1 to 10 of about 26,362 (117)

Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib

open access: yesPharmaceutics, 2020
Although celecoxib is quite effective in the management of inflammation-related diseases, especially arthritis, its use is limited by concerns including low bioavailability (BA), non-linear pharmacokinetic (PK) profile, and peak concentration-related ...
In-Soo Yoon, Yonghyun Lee, Wooseong Kim
exaly   +3 more sources

Celecoxib inhibits COX-2 and initiates YAP-dependent mitochondrial apoptosis via YBX1 shuttling in hepatocellular carcinoma [PDF]

open access: yesCell Communication and Signaling
Drug resistance poses a significant challenge in hepatocellular carcinoma (HCC) treatment. In this study, we aimed to assess the efficacy of celecoxib against HCC and uncover the underlying mechanism.
Zhe Hou   +9 more
doaj   +2 more sources

Drug‐Induced Cuproptosis Defines the Therapeutic Window of Celecoxib in Intervertebral Disc Degeneration via the HSP90‐RBX1 Axis [PDF]

open access: yesAdvanced Science
Intervertebral disc degeneration (IDD) is a major cause of low back pain, yet the biological effects of commonly used non‐steroidal anti‐inflammatory drugs (NSAIDs) on disc cells remain poorly understood.
Youfeng Guo   +11 more
doaj   +2 more sources

Effect of Cyclooxygenase-2 Inhibitors in Double J Stent Removal under Local Anesthesia

open access: yesThe Annals of African Surgery, 2021
Introduction: Celecoxib is a selective cyclooxygenase-2(COX-2) inhibitor that can reduce the inflammatory process during double J (DJ) stent removal procedure.
Rulianov Rulianov   +3 more
doaj   +1 more source

Towards safer anti-inflammatory therapy: synthesis of new thymol–pyrazole hybrids as dual COX-2/5-LOX inhibitors

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2023
New thymol − 1,5-disubstitutedpyrazole hybrids were synthesised as dual COX-2/5-LOX inhibitors. Compounds 8b, 8g, 8c, and 4a displayed in vitro inhibitory activity against COX-2 (IC50 = 0.043, 0.045, 0.063, and 0.068 µM) nearly equal to celecoxib (IC50 =
Mostafa M. M. El-Miligy   +5 more
doaj   +1 more source

Inhibition mechanism of the intracellular transporter Ca2+-pump from sarco-endoplasmic reticulum by the antitumor agent dimethyl-celecoxib. [PDF]

open access: yesPLoS ONE, 2014
Dimethyl-celecoxib is a celecoxib analog that lacks the capacity as cyclo-oxygenase-2 inhibitor and therefore the life-threatening effects but retains the antineoplastic properties. The action mechanism at the molecular level is unclear.
Ramón Coca   +4 more
doaj   +1 more source

Screening for autophagy/hypoxia/ferroptosis/pyroptosis-related genes of tendon injury and repair in a rat model after celecoxib and lactoferrin treatment

open access: yesJournal of Orthopaedic Surgery and Research, 2023
Background Tendon injuries are among the most common musculoskeletal disorders. Celecoxib possesses an effective anti-inflammatory activity in the tendon injury treatment. Lactoferrin has a great potential for the tendon regeneration.
Yaonan Zhang   +6 more
doaj   +1 more source

ANTI-INFLAMMATORY, ANALGESIC AND ULCEROGENIC POTENCY OF CURCUMIN IN COMPARISON WITH CELECOXIB AND PREDNISOLONE [PDF]

open access: yesBulletin of Pharmaceutical Sciences. Assiut University, 2022
The present study investigates the anti-inflammatory, analgesic effect, and gastric disturbance of curcumin compared with celecoxib and prednisolone.
Tarek Khamis   +4 more
doaj   +1 more source

INTERACTIONS OF CELECOXIB WITH DIFFERENT ANTIDIABETIC DRUGS IN DIABETIC RATS [PDF]

open access: yesBulletin of Pharmaceutical Sciences. Assiut University, 2016
The selective cyclooxygenase-2 inhibitor, celecoxib, can be prescribed to type 2 diabetic patients receiving oral hypoglycemic agents. This study was conducted to assess whether celecoxib affect the hypoglycemic activity of oral hypoglycemic agents in ...
Manar Nader, Shehta Said, Manar Helal
doaj   +1 more source

Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells. [PDF]

open access: yesPLoS ONE, 2013
Celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, can elicit anti-tumor effects in various malignancies. Here, we sought to clarify the role of autophagy in celecoxib-induced cytotoxicity in human urothelial carcinoma (UC) cells.
Kuo-How Huang   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy